TITLE

Farewell blast

AUTHOR(S)
Fenyvesi, C.
PUB. DATE
March 1992
SOURCE
U.S. News & World Report;3/2/92, Vol. 112 Issue 8, p28
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Reports that Donald Francis, 49, one of the nation's foremost AIDS specialists has quit government service after issuing a withering blast at interference from Washington politicians. Francis's pleas to colleagues at the Atlanta Centers for Disease Control; Those people Francis accused of delaying or preventing implementation of AIDS programs, including Budget Director Richard Darman and North Carolina Sen. Jesse Helms.
ACCESSION #
9203022381

 

Related Articles

  • Into another hot zone. Csatari, Jeffrey // Men's Health;Nov95, Vol. 10 Issue 9, p42 

    Presents an interview with AIDS-vaccine researcher Donald Francis. Reasons for funding difficulties for AIDS vaccine development; Importance of government assistance for vaccine tests; Opinion on why people with AIDS oppose AIDS vaccine trials.

  • Roof Line. Francis, Donald // Harpur Palate;Summer2006, Vol. 6 Issue 1, p68 

    Presents the short story "Roof Line," by Donald Francis.

  • Tovey's Beethoven. Berger, Arthur // New Republic;1/7/46, Vol. 114 Issue 1, p28 

    Reviews the book "Beethoven," by Donald Francis.

  • American witnesses testify in Japan about AIDS risks. Swinbanks, David // Nature;7/15/1993, Vol. 364 Issue 6434, p181 

    Reports on the testimony in Osaka district court by a former assistant director of the Centers for Disease Control (CDC), Donald Francis, about the contamination oof blood supplies sent by the United States to Japan. Continued advertisement of untreated products in Japan; Filing of suit by a...

  • AIDS vaccine results draw investor lawsuits.  // HIV Australia;Jun-Aug2003, Vol. 2 Issue 4, p37 

    Discusses a class-action lawsuit filed by U.S.-based law firm Milberg Weiss against VaxGen Biotech Co. and its CEO Lance Gordon and president Donald Francis for allegedly deceiving investors with a fraudulent scheme that concealed negative results from an AIDS vaccine trial. Facts of the case.

Share

Read the Article

Other Topics